US2697961082 - EGRX - A1XEDS (XNMS)
EAGLE PHARMACEUTICALS INC Share
0,55 USD
Current Prices from EAGLE PHARMACEUTICALS INC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
EGRX
|
USD
|
20.12.2024 21:42
|
0,55 USD
| 0,60 USD | -8,33 % |
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -15,38 % | -42,11 % | -86,78 % | -86,71 % | -88,91 % | -99,09 % |
Firmenprofil zu EAGLE PHARMACEUTICALS INC Aktie
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Investierte Fonds
Folgende Fonds haben in investiert: EAGLE PHARMACEUTICALS INC investiert:
Fonds | Vol. in Mio 25,27 | Anteil (%) 0,06 % |
Unternehmensdaten zur EAGLE PHARMACEUTICALS INC Aktie
Name EAGLE PHARMACEUTICALS INC
Firma Eagle Pharmaceuticals, Inc.
Symbol EGRX
Website https://www.eagleus.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A1XEDS
ISIN US2697961082
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Mr. Michael Graves
Marktkapitalisierung 51 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 50 Tice Boulevard, 07677 Woodcliff Lake
IPO Datum 2014-02-12
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 1E6.F |
NASDAQ | EGRX |
Weitere Aktien
Investoren die EAGLE PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.